Kareas-Athenes, Greece

Stamania Vassiliou

This inventor holds 1 USPTO granted patent. Top assignee: Other. Active years: 2003.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Stamania Vassiliou. Retrieved from https://idiyas.com/inventor/stamania-vassiliou

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:

goldMedal1 out of 834,513 
Other
 patents

Years Active: 2003

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Stamania Vassiliou: Innovator in Phosphinic Pseudo-Peptides

Introduction

Stamania Vassiliou is a notable inventor based in Kareas-Athenes, Greece. He has made significant contributions to the field of biochemistry, particularly in the development of innovative compounds.

Latest Patents

Vassiliou holds a patent for "Phosphinic pseudo-peptides that may be used as matrix zinc metalloprotease inhibitors." This invention showcases his expertise in creating compounds that have potential therapeutic applications.

Career Highlights

Throughout his career, Vassiliou has focused on advancing the understanding of metalloprotease inhibitors. His work has implications for various medical fields, including drug development and disease treatment.

Collaborations

He has collaborated with esteemed colleagues such as Fabrice Beau and Philippe Cuniasse. These partnerships have enhanced the research and development of his innovative ideas.

Conclusion

Stamania Vassiliou is a distinguished inventor whose work in phosphinic pseudo-peptides exemplifies the intersection of innovation and biochemistry. His contributions continue to influence the scientific community and pave the way for future advancements.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…